Skip to main content
. 2020 Jul 7;9(7):386. doi: 10.3390/antibiotics9070386

Figure 5.

Figure 5

Box-and-whisker plots illustrating the relative abundance of metabolite levels (VIP > 0.7, p < 0.05) of NCC and LpCC extracts using UHPLC-LTQ-Orbitrap-MS/MS. (A) N-(1-deoxy-1-fructosyl)phenylalanine, (B) 3-(2,3,4-trihydroxy-5-methoxyphenyl)propanoic acid, (C) glycyrol, (D) tryptophan, (E) benzoylmesaconine derivative, (F) kaempferol-diglucoside, (G) isorhamnetin 3,4’-diglucoside, (H) quercetin-diglucoside, (I) quercetin-hexoside, (J) saponin 1, (K) saponin 2, (L) kaempferol-glucoside, (M) saponin 3, (N) saponin 4, (O) saponin 5, (P) tianshic acid, and (Q) 12-hydroxystearic acid.